SCHEMBL7350898

SCHEMBL7350898

BrCc1cn[nH]c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23732868 0.80
Tert-Butyl Formate SCHEMBL27621547 0.78 TDP1 (0.42)
SCHEMBL14131007 0.78 NOS2 (0.44)
SCHEMBL21263656 0.78 NOS2 (0.44)
SCHEMBL129101 0.74
SCHEMBL1751269 0.74
SCHEMBL252482 0.74
SCHEMBL364376 0.74
SCHEMBL12821996 0.74
SCHEMBL28229251 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003964-B1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PYROXASULFONE ADAMA AGAN LTD (IL) 2024-09-18 EP disclosed
US-20230219937-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF SANOFI (FR) 2023-07-13 US disclosed
US-11059818-B2 Triazolopyridine inhibitors of myeloperoxidase BRISTOL-MYERS SQUIBB COMPANY (US) 2021-07-13 US disclosed
US-20200291015-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE BRISTOL MYERS SQUIBB CO (US) 2020-09-17 US disclosed
EP-0658546-B1 Novel 3-pyrazolecarboxamide derivatives with cannabinoid receptor affinity SANOFI SYNTHELABO (FR) 2001-05-23 EP disclosed
US-5462960-A Very good affinity for cannabinoid receptor; having psycho-tropic activity SANOFI (FR) 1995-10-31 US disclosed
EP-0658546-A1 Novel 3-pyrazolecarboxamide derivatives with cannabinoid receptor affinity SANOFI (FR) 1995-06-21 EP disclosed